AlzBiomarker
Alzheimer's Disease vs Control: GFAP (CSF)
Meta-analysis of five studies revealed a non-significant trend towards higher levels of glial fibrillary acid protein (GFAP) in the cerebrospinal fluid of people with Alzheimer's disease compared with control subjects (effect size = 1.502, p = 0.055).
Loading data...